GB0100288D0 - Virus strains - Google Patents

Virus strains

Info

Publication number
GB0100288D0
GB0100288D0 GB0100288A GB0100288A GB0100288D0 GB 0100288 D0 GB0100288 D0 GB 0100288D0 GB 0100288 A GB0100288 A GB 0100288A GB 0100288 A GB0100288 A GB 0100288A GB 0100288 D0 GB0100288 D0 GB 0100288D0
Authority
GB
United Kingdom
Prior art keywords
virus strains
strains
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0100288A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovex Ltd
Original Assignee
Biovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovex Ltd filed Critical Biovex Ltd
Priority to GB0100288A priority Critical patent/GB0100288D0/en
Priority to US10/181,692 priority patent/US7063835B2/en
Priority to AU2001226951A priority patent/AU2001226951B8/en
Priority to EP09014990A priority patent/EP2177619A1/en
Priority to EP01901288A priority patent/EP1252322B2/en
Priority to CA002398343A priority patent/CA2398343A1/en
Priority to KR1020027009412A priority patent/KR100768408B1/en
Priority to AT01901288T priority patent/ATE282708T1/en
Priority to DK01901288T priority patent/DK1252322T4/en
Priority to US10/181,697 priority patent/US7223593B2/en
Priority to AT01901292T priority patent/ATE312189T1/en
Priority to BRPI0107737A priority patent/BRPI0107737B8/en
Priority to IL15067801A priority patent/IL150678A0/en
Priority to PT01901288T priority patent/PT1252322E/en
Priority to CA2398335A priority patent/CA2398335C/en
Priority to CN01806743A priority patent/CN1418255A/en
Priority to GB0219033A priority patent/GB2374873C/en
Priority to DE60115600T priority patent/DE60115600T2/en
Priority to AU2695101A priority patent/AU2695101A/en
Priority to PCT/GB2001/000225 priority patent/WO2001053505A2/en
Priority to EP05011798A priority patent/EP1568779A1/en
Priority to KR1020027009410A priority patent/KR100802403B1/en
Priority to EP01901292A priority patent/EP1252323B1/en
Priority to DK01901292T priority patent/DK1252323T3/en
Priority to ES01901292T priority patent/ES2254359T3/en
Priority to BRPI0107736A priority patent/BRPI0107736B8/en
Priority to BR0107736-8A priority patent/BR0107736A/en
Priority to PCT/GB2001/000229 priority patent/WO2001053506A2/en
Priority to DE60107203T priority patent/DE60107203T3/en
Priority to CNB018067506A priority patent/CN1250732C/en
Priority to GB0219030A priority patent/GB2375113B/en
Priority to ES01901288T priority patent/ES2233600T5/en
Priority to AU26947/01A priority patent/AU782659C/en
Priority to IL15067701A priority patent/IL150677A0/en
Priority to JP2001553368A priority patent/JP4921669B2/en
Priority to JP2001553367A priority patent/JP4810042B2/en
Publication of GB0100288D0 publication Critical patent/GB0100288D0/en
Priority to IL150677A priority patent/IL150677A/en
Priority to IL150678A priority patent/IL150678A/en
Priority to HK02108579.0A priority patent/HK1047451B/en
Priority to HK02108740.4A priority patent/HK1047297B/en
Priority to US11/372,613 priority patent/US7537924B2/en
Priority to US11/738,807 priority patent/US8277818B2/en
Priority to US12/425,952 priority patent/US20090220460A1/en
Priority to JP2011238257A priority patent/JP2012072156A/en
Priority to US13/399,868 priority patent/US20120164108A1/en
Priority to US13/600,711 priority patent/US8680068B2/en
Priority to US14/174,521 priority patent/US20140154215A1/en
Priority to US14/175,855 priority patent/US10301600B2/en
Priority to US14/700,036 priority patent/US20150232812A1/en
Priority to JP2015138227A priority patent/JP6424145B2/en
Priority to LU93100C priority patent/LU93100I2/en
Priority to LU93101C priority patent/LU93101I2/en
Priority to BE2016C033C priority patent/BE2016C033I2/fr
Priority to NL300820C priority patent/NL300820I2/nl
Priority to NL300821C priority patent/NL300821I2/nl
Priority to FR16C0026C priority patent/FR16C0026I2/en
Priority to CY2016020C priority patent/CY2016020I1/en
Priority to CY2016021C priority patent/CY2016021I1/en
Priority to JP2017037827A priority patent/JP2017132779A/en
Priority to JP2018218735A priority patent/JP6644378B2/en
Priority to US16/372,800 priority patent/US20200032218A1/en
Priority to US16/376,089 priority patent/US20200032219A1/en
Ceased legal-status Critical Current

Links

GB0100288A 2000-01-21 2001-01-05 Virus strains Ceased GB0100288D0 (en)

Priority Applications (62)

Application Number Priority Date Filing Date Title
GB0100288A GB0100288D0 (en) 2001-01-05 2001-01-05 Virus strains
US10/181,692 US7063835B2 (en) 2000-01-21 2001-01-22 Virus strains
AU2001226951A AU2001226951B8 (en) 2000-01-21 2001-01-22 Virus strains for the oncolytic treatment of cancer
EP09014990A EP2177619A1 (en) 2000-01-21 2001-01-22 HSV strains for the oncolytic treatment of cancer
EP01901288A EP1252322B2 (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy
CA002398343A CA2398343A1 (en) 2000-01-21 2001-01-22 Virus strains for the oncolytic treatment of cancer
KR1020027009412A KR100768408B1 (en) 2000-01-21 2001-01-22 Herpes Virus Strains
AT01901288T ATE282708T1 (en) 2000-01-21 2001-01-22 HERPES VIRUS STRAINS FOR GENE THERAPY
DK01901288T DK1252322T4 (en) 2000-01-21 2001-01-22 Herpesvirus strain for gene therapy
US10/181,697 US7223593B2 (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy
AT01901292T ATE312189T1 (en) 2000-01-21 2001-01-22 VIRUS STRAINS FOR ONCOLYTIC TREATMENT OF CANCER
BRPI0107737A BRPI0107737B8 (en) 2000-01-21 2001-01-22 herpes simplex virus 1 (hsv1), use of hsv1, and pharmaceutical composition
IL15067801A IL150678A0 (en) 2000-01-21 2001-01-22 Herpes virus strains
PT01901288T PT1252322E (en) 2000-01-21 2001-01-22 HERPES VIRUS STRETCHES FOR GENE THERAPY
CA2398335A CA2398335C (en) 2000-01-21 2001-01-22 Herpes virus strains
CN01806743A CN1418255A (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy
GB0219033A GB2374873C (en) 2000-01-21 2001-01-22 Herpes virus strains
DE60115600T DE60115600T2 (en) 2000-01-21 2001-01-22 VIRUSES FOR ONCOLYTIC TREATMENT OF CANCER
AU2695101A AU2695101A (en) 2000-01-21 2001-01-22 Virus strains
PCT/GB2001/000225 WO2001053505A2 (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy
EP05011798A EP1568779A1 (en) 2000-01-21 2001-01-22 HSV strains for the oncolytic treatment of cancer
KR1020027009410A KR100802403B1 (en) 2000-01-21 2001-01-22 Virus Strains
EP01901292A EP1252323B1 (en) 2000-01-21 2001-01-22 Virus strains for the oncolytic treatment of cancer
DK01901292T DK1252323T3 (en) 2000-01-21 2001-01-22 Virus strains for the oncolytic treatment of cancer
ES01901292T ES2254359T3 (en) 2000-01-21 2001-01-22 VIRAL CEPA FOR THE ONCOLITIC TREATMENT OF CANCERES.
BRPI0107736A BRPI0107736B8 (en) 2000-01-21 2001-01-22 hsv1 js1 strain, pharmaceutical composition, and use of an hsv1 js1 strain
BR0107736-8A BR0107736A (en) 2000-01-21 2001-01-22 Use of a non-laboratory virus strain, methods for determining whether a gene has an effect on a phenotype associated with a peripheral and central nervous system disorder or on a peripheral and central nervous system cell to determine whether a gene encodes an antigen associated with a pathogenic infection or cancer, to determine the suitability of a non-laboratory virus strain for modification to a modified strain, to determine whether a gene enhances the anti-tumor effects of a virus, and to produce an oncolytic non-laboratory virus strain. , modified, non-laboratory virus strain, use of a gene, hsv1 js1 strain, pharmaceutical composition, and, methods for treating a tumor in an individual, supplying a gene to an individual and treating or preventing a disorder of the peripheral nervous systems and central
PCT/GB2001/000229 WO2001053506A2 (en) 2000-01-21 2001-01-22 Virus strains for the oncolytic treatment of cancer
DE60107203T DE60107203T3 (en) 2000-01-21 2001-01-22 HERPES VIRUSES FOR GENE THERAPY
CNB018067506A CN1250732C (en) 2000-01-21 2001-01-22 Virus strains
GB0219030A GB2375113B (en) 2000-01-21 2001-01-22 A modified, oncolytic, non-laboratory HSV strain and its use in treating cancer
ES01901288T ES2233600T5 (en) 2000-01-21 2001-01-22 VIRUSES OF HERPES.
AU26947/01A AU782659C (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy
IL15067701A IL150677A0 (en) 2000-01-21 2001-01-22 Virus strains
JP2001553368A JP4921669B2 (en) 2000-01-21 2001-01-22 Virus strain
JP2001553367A JP4810042B2 (en) 2000-01-21 2001-01-22 Herpesvirus strain
IL150677A IL150677A (en) 2000-01-21 2002-07-10 Virus strains
IL150678A IL150678A (en) 2000-01-21 2002-07-10 Herpes virus strains
HK02108579.0A HK1047451B (en) 2000-01-21 2002-11-28 A modified, oncolytic, non-laboratory hsv strain and its use in treating cancer
HK02108740.4A HK1047297B (en) 2000-01-21 2002-11-30 Herpes virus strains
US11/372,613 US7537924B2 (en) 2000-01-21 2006-03-10 Virus strains
US11/738,807 US8277818B2 (en) 2000-01-21 2007-04-23 Herpes virus strains for gene therapy
US12/425,952 US20090220460A1 (en) 2000-01-21 2009-04-17 Virus strains
JP2011238257A JP2012072156A (en) 2000-01-21 2011-10-31 Virus strain
US13/399,868 US20120164108A1 (en) 2000-01-21 2012-02-17 Virus strains
US13/600,711 US8680068B2 (en) 2000-01-21 2012-08-31 Herpes virus strains
US14/174,521 US20140154215A1 (en) 2000-01-21 2014-02-06 Herpes virus strains
US14/175,855 US10301600B2 (en) 2000-01-21 2014-02-07 Virus strains
US14/700,036 US20150232812A1 (en) 2000-01-21 2015-04-29 Herpes virus strains
JP2015138227A JP6424145B2 (en) 2000-01-21 2015-07-10 Virus strain
LU93100C LU93100I2 (en) 2000-01-21 2016-06-08 TALIMOGENE LAHERPAREPVEC AND ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVES (IMLYGIC)
LU93101C LU93101I2 (en) 2000-01-21 2016-06-08 IMLYGIC-TALIMOGENE LAHERPAREPVEC
BE2016C033C BE2016C033I2 (en) 2000-01-21 2016-06-14
NL300820C NL300820I2 (en) 2000-01-21 2016-06-14
NL300821C NL300821I2 (en) 2000-01-21 2016-06-14
FR16C0026C FR16C0026I2 (en) 2000-01-21 2016-06-15 HERPETIC VIRUS STRAINS FOR GENE THERAPY
CY2016020C CY2016020I1 (en) 2000-01-21 2016-06-15 HERPES VIRUS STRAIN FOR GENE THERAPY
CY2016021C CY2016021I1 (en) 2000-01-21 2016-06-15 VIRUS STRAIN FOR THE ONCOLYTIC THERAPY OF CANCER
JP2017037827A JP2017132779A (en) 2000-01-21 2017-03-01 Virus strain
JP2018218735A JP6644378B2 (en) 2000-01-21 2018-11-22 Virus strain
US16/372,800 US20200032218A1 (en) 2000-01-21 2019-04-02 Virus strains
US16/376,089 US20200032219A1 (en) 2000-01-21 2019-04-05 Herpes virus strains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0100288A GB0100288D0 (en) 2001-01-05 2001-01-05 Virus strains

Publications (1)

Publication Number Publication Date
GB0100288D0 true GB0100288D0 (en) 2001-02-14

Family

ID=9906321

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0100288A Ceased GB0100288D0 (en) 2000-01-21 2001-01-05 Virus strains

Country Status (1)

Country Link
GB (1) GB0100288D0 (en)

Similar Documents

Publication Publication Date Title
HUP0402471A3 (en) Vaccine
GB0407935D0 (en) Vaccine
HUP0402259A3 (en) Vaccines
GB2380818B (en) ASIC design technique
IL157498A0 (en) Vaccine
EP1423141A4 (en) Vaccine
GB0306611D0 (en) Novel vaccine
EP1435788A4 (en) Lysin-deficient bacteriophages having reduced immunogenicity
IL153879A0 (en) Modified virus
GB0121171D0 (en) Vaccine
GB0001475D0 (en) Virus strains
HU0400176V0 (en) Improved gasketseal
AU147708S (en) Vacuum
GB0001476D0 (en) Herpes virus strains
GB0105238D0 (en) Vaccines
GB0100430D0 (en) Virus strains
GB0100288D0 (en) Virus strains
EP1355643A4 (en) Epoxyvibsanin b
GB0002854D0 (en) Virus strains
GB0106066D0 (en) Psuedotyped viruses
GB0103867D0 (en) Vaccine
GB0106589D0 (en) Vaccine
GB0115496D0 (en) Vaccine
GB0130823D0 (en) Vaccine
GB0124137D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)